NeuroSearch A/S (NEUR) to Release Q4 2007 Earnings March 4

NeuroSearch A/S (CPH:NEUR) will release the fourth quarter earnings for 2007 on March 4.

A biopharmaceutical company, NeuroSearch A/S is based in Denmark.  The company primarily engages in the research and development of treatments for diseases in the central nervous system (CNS) and other diseases which are generally treated by ion channel modulation.  The company portfolio offers compounds to treat attention deficit hyperactivity disorder, anxiety, disorders, cancer, chronic obstructive pulmonary disease, depression, epilepsy, pain and Parkinson’s disease.

The company is operated through three wholly owned subsidiaries.

Poseidon Pharmacueticals A/S is involved in the research and development on treating of non CNS diseases, including respiratory and immune systems.

NeuroScreen ApS screens potential neurotoxic and neuroactive compounds.

NsExplorer A/S is focused on new mechanism to treat tension headaches.

For more Earnings related events or to post your own events, visit:

http://events.finditt.com/Events_list.aspx?catid=13